FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

COS Linda Howard

The recent FDA guidance on conducting clinical trial during the COVID-19 pandemic mirrors our response policy to minimize study participant contact and engage in phone or video calls wherever possible. Great to see COS is ahead of the curve.

Read full FDA guidance as PDF here